Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of Hugan Pian in acute drug-induced liver injury
CTR20212719Phase 2Active
- Sponsor
- Sunflower Pharmaceutical Group
- Start
- Nov 2021
- Countries
- 1
01
Overview
A Phase 2 trial of hugan pian in Drug-induced hepatitis (DILI), sponsored by Sunflower Pharmaceutical Group. Started Nov 2021; status: active.
02
Drugs
hugan pian
03
Conditions
Drug-induced hepatitis (DILI)
Beyond the preview
Go deeper on CTR20212719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212719.